abstract |
The present invention relates, at least in part, to compositions and related methods, including peptides that bind to MHC II. In one embodiment, the peptides that bind to MHC II include a peptide that is at least 70% identical to a natural peptide that binds to HLA-DP, a peptide that binds to HLA-DQ, or a peptide that binds to HLA-DR. |